Area of research
Oncology · Immunology
Research interest
Research interests include Phagocytosis and Immune Regulation, Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, and Pancreatic and Hepatic Oncology Research.
Targeting HER3-dependent activation of nuclear AKT improves radiotherapy of non-small cell lung cancer
Targeting AKT/PKB to improve treatment outcomes for solid tumors
Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast Cancers
EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma
Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patients
Akt1 and Akt3 but not Akt2 through interaction with DNA-PKcs stimulate proliferation and post-irradiation cell survival of K-RAS-mutated cancer cells
Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule Polyphenol
AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma
AXL Mediates Resistance to Cetuximab Therapy
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy
Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-Negative Breast Cancer
Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer
Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics